Company Number: 14738540

Analysis Date: 2025-07-29 13:05 UTC

Financial Health Assessment for SQUPSIES LTD (As at 31 March 2024)

---

1. Financial Health Score: D

Explanation:
SQUPSIES LTD shows early-stage operational signs with limited financial activity but is currently in a precarious position with negative net current assets and shareholders’ funds. This indicates symptoms of financial distress that need addressing promptly to avoid further deterioration.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	61	Minimal investment in long-term assets, typical for a newly incorporated micro company.
Current Assets	18,347	Cash or receivables available, a healthy "cash flow" reservoir at this stage.
Current Liabilities	19,598	Short-term debts slightly exceeding current assets, creating a working capital deficit.
Net Current Assets	(1,251)	Negative working capital indicating the company owes more in the short term than it owns.
Total Assets Less Current Liabilities	(1,190)	Overall, the company has a negative net asset position; liabilities exceed assets.
Shareholders’ Funds	(1,190)	Negative equity suggests accumulated losses or undercapitalization since inception.
Average Employees	Nil	No employees, which aligns with low operational activity or early business stage.

Vital Signs Interpretation:

• The company's "heartbeat"—its liquidity—is fragile due to negative net current assets.
• The "immune system," represented by shareholders’ funds, is compromised, showing the business is operating with negative equity, a warning sign similar to a patient with low immunity.
• Lack of employees and minimal fixed assets reflect very early development or possibly a non-trading status.

---

3. Diagnosis

SQUPSIES LTD is in an embryonic financial stage, showing signs typical for a start-up or a micro-entity in its first financial year. The negative working capital and shareholders’ deficit indicate the company is currently running at a loss or has been funded primarily through liabilities rather than equity injections.

This financial "symptom" suggests that the company may be relying on short-term financing or deferred payments to operate, which is unsustainable without a clear path to positive cash flow or asset growth. The absence of employees and minimal asset base also imply limited business operations so far.

There is no indication of insolvency or liquidation; however, the company’s financial "vital signs" should be monitored closely to avoid worsening liquidity or solvency conditions.

---

4. Recommendations

Immediate Actions:

• Capital Injection: Consider an equity injection or shareholder loan to strengthen the balance sheet and restore positive net assets. This is the equivalent of boosting a patient’s immunity to withstand operational pressures.

• Cash Flow Management: Tighten control on cash inflows and outflows to prevent negative working capital from worsening. Aim to convert current liabilities into longer-term obligations where possible.

• Operational Review: Assess the business model and revenue generation plans since no employees and minimal fixed assets suggest limited operational activity. A clear plan to generate sustainable income is critical.

• Cost Control: Minimize non-essential expenses until the company achieves positive cash flow and net assets.

• Financial Monitoring: Implement monthly financial reviews to track liquidity and solvency closely, enabling early intervention if symptoms of financial distress worsen.

---

Executive Summary